Lv53
1350 积分 2023-09-22 加入
Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) Degraders for Treating Inflammatory Diseases: Advances and Prospects
1天前
已完结
From bench to bloodstream: Lipid nanoparticles drive on-demand CAR-T cells
29天前
已完结
Cancer-fighting CAR T cells show promising results for hard-to-treat tumours
29天前
已关闭
In vivo chimeric antigen receptor (CAR)-T cell therapy
1个月前
已完结
In vivo CAR T cell generation to treat cancer and autoimmune disease
1个月前
已完结
63880 A First-in-Human Phase 1a Randomized, Double-Blind Single-Ascending Dose Study of NAV-240, an anti-OX40L/TNF-alpha Bispecific Antibody, in Healthy Volunteers
1个月前
已完结
Cloning of human thymic stromal lymphopoietin (TSLP) and signaling mechanisms leading to proliferation
2个月前
已完结
A shared neoantigen vaccine combined with immune checkpoint blockade for advanced metastatic solid tumors: phase 1 trial interim results
2个月前
已完结
Recent Progress and Future Perspectives on Anti-Hyperuricemic Agents
3个月前
已完结
Sensitization of tumours to immunotherapy by boosting early type-I interferon responses enables epitope spreading
4个月前
已完结
皖公网安备34019202002308
